American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 27,447 | 25,745 | 52,702 | 53,935 | 54,052 |
| Cost of Goods | 24,255 | 18,064 | 29,076 | 28,730 | 28,207 |
| Gross Profit | 3,192 | 7,682 | 23,626 | 25,204 | 25,845 |
| Operating Expenses | 25,666 | 22,835 | 84,168 | 20,407 | 19,774 |
| Operating Income | -22,220 | -15,090 | -60,466 | 5,528 | 6,278 |
| Interest Expense | 1,808 | 1,743 | 1,759 | 1,803 | 1,534 |
| Other Income | -1,230 | 90 | -20,919 | 1,754 | 1,131 |
| Pre-tax Income | -25,257 | -16,744 | -83,144 | 5,479 | 5,875 |
| Income Tax | 511 | 443 | -3,457 | -2,203 | 3,170 |
| Net Income Continuous | -25,768 | -17,187 | -79,688 | 7,682 | 2,705 |
| Minority Interests | 19 | -30 | -1,027 | -28 | 11 |
| Net Income | $-25,787 | $-17,157 | $-78,661 | $7,710 | $2,695 |
| EPS Basic Total Ops | -330.00 | -215.00 | -1,045.00 | 100.00 | 35.00 |
| EPS Basic Continuous Ops | -327.75 | -217.68 | -1,064.92 | 102.64 | 36.23 |
| EPS Diluted Total Ops | -330.00 | -215.00 | -1,045.00 | 100.00 | 35.00 |
| EPS Diluted Continuous Ops | -327.75 | -217.68 | -1,061.60 | 100.39 | 35.31 |
| EBITDA(a) | $-19,084 | $-11,833 | $-57,066 | $8,843 | $9,571 |